共 50 条
- [22] Summary of consensus recommendations for managing latent tuberculosis in therapies with b/tsDMARDs JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2023, 30 (02): : 54 - 58
- [23] Reactivation of tuberculosis during treatment with inhibitors of TNF: understanding and prevention Discussion BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (1-2): : 327 - 329
- [25] Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents JOURNAL OF CROHNS & COLITIS, 2008, 2 (03): : 250 - 254
- [27] FOLLOW UP RESULTS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS TREATED WITH ANTI-TNF-ALPHA NOBEL MEDICUS, 2014, 10 (01): : 47 - 52
- [29] Assessment of the impact of compliance with recommendations to avoid active tuberculosis in patients treated with TNF antagonists. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S244 - S245